POM-V Prescription Required Companion Animal

Chanear Ear Drops and Cutaneous Suspension for Cats and Dogs

Active ingredients: Miconazole Nitrate, Polymyxin B Sulphate, Prednisolone Acetate

Form

Drops

Species

Cats Dogs

Manufacturer

Chanelle Pharmaceuticals Manufacturing Ltd

VMD MA No.

08749/5185

What it's used for

bacteria Pseudomonas aeruginosa. For the topical treatment of otitis externa and skin infections caused by fungi and yeasts: TrichophytonMicrosporum spp.,...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Miconazole Nitrate + Polymyx...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Chanear Ear Drops and Cutaneous Suspension for Cats and Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

bacteria Pseudomonas aeruginosa.
For the topical treatment of otitis externa and skin infections caused by fungi and
yeasts: TrichophytonMicrosporum spp., Malassezia pachydermatis, Candida
spp.
For the topical treatment of otitis externa caused by the ear mite Otodectes cynotis
and complicated by microorganisms sensitive to miconazole and polymyxin B.
The product also has anti-inflammatory and anti-pruritic activity.

Amended pages: December 2025

Routes of administration: For instillation in the external auditory canal or for
cutaneous application.
Shake the bottle vigorously and ensure the product is fully resuspended before use.
At the beginning of treatment, hair surrounding or covering the lesions must be
clipped; this should be repeated during treatment if necessary.
Ears: Clean the auditory canal and place a few drops of the product into the ear twice
daily. For infections caused by Otodectes cynotis, instil five drops twice daily for 14
days.
Massage the ear and the auditory canal gently but thoroughly to ensure proper
distribution. The success of the treatment should be verified by a veterinarian before
discontinuing treatment.
Skin: Having ensured the area to be treated is clean, apply a few drops of the
product (depending on lesion size) twice a day and rub well.
Treatment should be continued until a few days after complete disappearance of the
clinical symptoms. In some obstinate cases, treatment may be required for 2 to 3
weeks (see also 3.6). In cases where prolonged treatment is necessary repeated
clinical examinations including a re-assessment of the diagnosis are required.
Where ear mite infection is present, consideration should be given to treating both
ears even if infestation is only apparent in one ear.

Do not use:
•
medicinal product, as well as to other corticosteroids, to other azole antifungal
agents, or to any of the excipients.
•
•
•
•
miconazole is known.
•

Cats and dogs:
Very rare
(<1 animal / 10,000 animals treated,
including isolated reports):
Deafness*
Impaired hearing*
*Mainly in elderly dogs. If this occurs, treatment should be stopped. Decreased
hearing or deafness is generally temporary in nature.
Prolonged use of topical steroids can cause skin discoloration and delay wound
healing.
The conventional adverse effects of corticosteroids can occur (disturbance of
biochemical parameters such as increased cortisol and hepatic enzyme levels).
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.

Amended pages: December 2025

As the product is a prescription only medicine, treatment should be closely
supervised by a veterinary practitioner. Bacterial and fungal otitis is often secondary
in nature. The underlying cause should be identified and treated.

Special precautions for safe use in the target species:
For external use only.
Before treating with the product, the integrity of the tympanic membrane must be
verified.
Avoid contact with eyes in animals. In case of accidental contact, rinse thoroughly
with water.
An antibiotic with a lower risk of antimicrobial resistance selection (lower AMEG
category) should be used for first line treatment where susceptibility testing suggests
the likely efficacy of this approach. This antimicrobial combination should only be
used where diagnostic testing has indicated the need for simultaneous administration
of each of the active substances.
Use of the product should be based on identification and susceptibility testing of the
target pathogen(s).
If this is not possible, therapy should be based on epidemiological information and
knowledge of the susceptibility of the target pathogens at the local or regional level.
Use of the product should be in accordance with official, national and regional
antimicrobial policies.
If there is overgrowth of resistance growth of resistant bacteria and/or fungi the use
of treatment with this veterinary medicinal product should be discontinued and
treatment with an appropriate alternative treatment should be initiated.
In cases of persistent infestations with Otodectes cynotis (ear mites) systemic
treatment with an appropriate acaricide should be considered.

Amended pages: December 2025
Systemic corticosteroid effects are possible, especially when the product is used
under an occlusive dressing, on extensive skin lesions, with increased skin blood
flow, or if the product is ingested by licking.
Oral ingestion of the product by treated animals or animals having contact with
treated animals should be avoided.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
People with known hypersensitivity to prednisolone, polymyxin B or miconazole
should avoid contact with the veterinary medicinal product.
The product may cause irritation to skin and eyes.
Corticosteroids may produce irreversible effects in the skin. They can be absorbed
and may have harmful effects, especially with frequent and extensive contact or in
pregnancy.
Avoid contact with skin or eyes. Always wear single use disposable gloves when
applying the product to animals. In case of accidental contact, skin or eyes should be
rinsed immediately with plenty of water. Wash hands after use.
Accidental ingestion of the product by a child may cause gastro-intestinal
disturbances. Do not leave the filled dropper unattended. In case of accidental
ingestion, seek medical advice immediately and show the leaflet or the label to the
physician
Special precautions for the protection of the environment:
Not applicable.

No data available.

Do not store above 25 °C.
Do not refrigerate.
Keep the container in the outer carton in order to protect from light.

Not applicable.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.